Diagnostics names react to surveillance data
A mild move, driven by wastewater and hospitalisation trends.
Event on Nov 25 · in 3 weeks
The prediction, in plain language
Markets say noMarkets bet the other way, they expect a setback or a refusal.
Prices imply 20% for this outcome, weakening by 3 points in 24h, with low confidence.
Treat this as a weak indication, not a forecast: confidence is low and the reading moves a lot.
This is what market prices currently imply, not a certainty. Readings change as new information arrives.
-3 / 24h
Confidence: Low
Sign in to follow this signal and set alerts.
Sign inWhy this signal
Data, Vaccine equities strengthened by 2 points over 24 hours, with volume above its 30-day average. Cross-checked against 2 linked markets.
Context, Drug pipelines and reimbursement decisions drive the sector's repricing.
Interpretation, Taken together, prices point to an implied probability of 22% and a signal strength of 44/100 on this event.
Uncertainty, Confidence is low. This is what prices imply today, not a forecast, a single surprise can reverse it.
Cross-market confirmation
Diagnostics
+1.1%
What could change it
- Surveillance reports
- Vaccine contracts
Follow the story
Loading the latest headlines…
